MedTrace Logo

Effects of Deloading Periods in Resistance Training on Muscular Strength and Hypertrophy

NCT06825052 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2025-02-13

No results posted yet for this study

Summary

This study investigates the effects of deloading periods (short breaks or reductions in training volume) in a 8-week resistance training program on muscle strength and hypertrophy in young, untrained individuals.

Participants were randomly assigned to two training conditions:

Deload Training Group: Reduced training volume for one week every four weeks. Continuous Training Group: Regular training without reductions. Muscle thickness was measured using ultrasound, and muscle strength was evaluated through a 10-repetition maximum (10RM) test before and after the intervention.

The findings showed that both training strategies led to significant increases in muscle strength and size, with no major differences between groups. This suggests that incorporating deloading periods does not negatively impact muscle development and may serve as an effective alternative for individuals with time constraints or minor injuries.

This study was conducted at Gaziantep University, Faculty of Sports Sciences, with approval from the university's ethics committee.

Conditions

  • Muscle Hypertrophy in Healthy Young Men

Interventions

BEHAVIORAL

Resistance Training with Deloading Periods

Participants performed an 8-week unilateral resistance training program in which training volume and intensity were reduced during weeks 4 and 8 to facilitate recovery and adaptation.

BEHAVIORAL

Continuous Resistance Training

Participants followed an 8-week unilateral resistance training program without any deloading periods. Training volume and intensity remained consistent throughout the study.

Sponsors & Collaborators

  • University of Gaziantep

    lead OTHER

Principal Investigators

  • Zarife Pancar Assistant Professor,, PhD · University of Gaziantep

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2024-06-25
Completion
2024-08-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06825052 on ClinicalTrials.gov